We are a dynamic team of 50 people with a passion for science and delivering for our customers.
At Ingenza we are turbocharging biological systems to make everything from therapeutics to enzymes and consumer products, addressing challenges in human health and the global environment. We are a high-growth SME, driven by our values, culture of integrity, and scientific excellence.
We are a dynamic team of 50 people with a passion for science and delivering for our customers.
At Ingenza we are turbocharging biological systems to make everything from therapeutics to enzymes and consumer products, addressing challenges in human health and the global environment. We are a high-growth SME, driven by our values, culture of integrity, and scientific excellence.
𝗤𝘂𝗶𝘇 𝗡𝗶𝗴𝗵𝘁 𝘄𝗶𝘁𝗵 𝗖𝗮𝘁 | 𝗼𝟮𝗵 𝗰𝗼-𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆
Join us for an evening of quiz, conversation and connection during 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗼𝗻 𝗧𝗮𝗿𝗴𝗲𝘁 in Boston.
On Monday, 28 September, from 6:00–8:30 PM, we’re bringing together scientists, biotech professionals and curious minds for a fun quiz spanning 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲𝘀, 𝗕𝗶𝗼𝘁𝗲𝗰𝗵, 𝗣𝗼𝗽 𝗖𝘂𝗹𝘁𝘂𝗿𝗲, 𝗚𝗲𝗻𝗲𝗿𝗮𝗹 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲.
Hosted by Catherine Stace, 𝗩𝗣 - 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 & 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗥𝗲𝗹𝗮𝘁𝗶𝗼𝗻𝘀𝗵𝗶𝗽𝘀, the evening is all about friendly competition, unexpected questions and great conversations beyond the conference floor.
Download the UK Life Sciences Innovation Signals Report
The UK life sciences sector continues to attract investment, strengthen research capabilities and advance scientific innovation. The key question facing the market is no longer whether innovation is being created. It is whether innovation can be converted into commercial growth, healthcare adoption and measurable patient impact.
PIA Commercial are pleased to confirm the launch of our new website
As One Nucleus members we work closely with life science companies in the UK and overseas to establish the insurance protection they require, and meets those needs
Please have a look at the website which details how we can help you, and feel free to contact us by telephone , email, or via the website
Kind regards
The Earlham Institute has been awarded funding by the Gordon and Betty Moore Foundation to develop Protist Omics at Scale, a three-year international methods-development programme run in partnership with the Scottish Association for Marine Science, home of the Culture Collection of Algae and Protozoa, and the Bigelow Laboratory for Ocean Sciences.
Cambridge, UK, 28 July 2026 - One Nucleus expands its portfolio of member benefits through o2h co-discovery bringing discounted exclusive access for eligible One Nucleus members to specialist in-vitro ADME and DMPK services designed to support early-stage drug discovery.
Join Cambridge Network to welcome Howes Percival as our speakers to explain how data protection law is changing and what you need to know now to comply.
Data Protection law is constantly evolving. The Data (Use and Access) Act 2025 (DUAA), which amends the UK GDPR and Data Protection Act 2018, implemented a number of changes during the early part of 2026 with the last provisions taking effect from 19 June. It introduced some new key changes for UK organizations.
Pioneer Group and Oxford Properties have announced that Syncona Investment Management Ltd (SIML), a leading life science investment manager, is moving into Victoria House, a leading hub for life sciences in London.
Developed by Pioneer Group and Oxford Properties, Victoria House in Bloomsbury, London continues to build one of London’s most inspiring life science communities, where an ever-growing number of pioneering organisations are driving innovation across science, biopharmaceuticals, gene therapies, synthetic biology and AI.
TBI is a leading cause of death and disability, costs the UK economy over £10 billion, and the global economy over $500 billion, annually. Outcomes from TBI are poor – even with “mild” TBI, 30% of patients show incomplete recovery at six months post-injury. The scope for improvement (and potential market opportunity) is substantial. While many past trials have failed, the substantial new knowledge provides a timely opportunity to address this issue.